CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2022	Sep. 30, 2021
Current assets:
Cash and cash equivalents	$ 15,215,285	$ 6,554,948
Accounts receivable, net of allowance of $330,853 and $29,821 at September 30, 2022 and 2021, respectively	3,067,544	2,804,039
Inventories	602,244	1,369,933
Prepaid expenses and other current assets	1,058,056	568,881
Total current assets	19,943,129	11,297,801
Property and equipment, net	2,222,988	3,023,915
Other assets:
Deposits	98,997	95,040
Total assets	22,265,114	14,416,756
Current liabilities:
Accounts payable and accrued liabilities	3,621,751	2,991,343
Deferred revenue	563,557	281,000
Total current liabilities	4,185,308	3,272,343
Long term accrued liabilities	31,467	31,467
Common Warrant liability	5,139,400
Total liabilities	9,356,175	3,303,810
Commitments and contingencies (Note K)
Applied DNA Sciences, Inc. stockholders' equity:
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of September 30, 2022 and 2021, respectively	0	0
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of September 30, 2022 and 2021, 12,908,520 and 7,486,120 shares issued and outstanding as of September 30, 2022 and 2021, respectively	12,909	7,488
Additional paid in capital	305,399,008	295,228,272
Accumulated deficit	(292,500,088)	(284,122,092)
Applied DNA Sciences, Inc. stockholders' equity:	12,911,829	11,113,668
Noncontrolling interest	(2,890)	(722)
Total equity	12,908,939	11,112,946
Total liabilities and equity	22,265,114	14,416,756
Series A Preferred Stock
Applied DNA Sciences, Inc. stockholders' equity:
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of September 30, 2022 and 2021, respectively	0	0
Series B Preferred Stock
Applied DNA Sciences, Inc. stockholders' equity:
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of September 30, 2022 and 2021, respectively	$ 0	$ 0